Health Care & Life Sciences » Biotechnology | XTL Biopharmaceuticals Ltd.

XTL Biopharmaceuticals Ltd.

XTL Biopharmaceuticals Ltd. ADR
Stock Exchange NASDAQ Stock Market
EPS
$1.17
Market Cap
$9.72 M
Shares Outstanding
5.14 M
Public Float
-

Profile

Address
5 Badner Sreet
Ramat Gan HM 4365603
Israel
Employees -
Website http://www.xtlbio.com
Updated 07/08/2019
XTL Biopharmaceuticals Ltd is a biopharmaceutical company, which engages in the acquisition and development of pharmaceutical drugs. Its drug development program focuses on the treatment of systemic lupus erythematosus. The company was founded on March 9, 1993 and is headquartered in Raanana, Israel.

Financials

View All

Shlomo Spokone Shalev
Chairman
Alexander Rabinovitch
Non-Executive Director